Other OTC - Delayed Quote USD

Rafina Innovations Inc. (VICA)

0.0001 0.0000 (0.00%)
At close: March 25 at 11:06 AM EDT
Key Events
Loading Chart for VICA
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0015
  • Volume 20,150
  • Avg. Volume 314
  • Market Cap (intraday) 12,202
  • Beta (5Y Monthly) 12.45
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.

rafina-innovations.com

4

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: VICA

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VICA
93.33%
S&P 500
6.92%

1-Year Return

VICA
93.33%
S&P 500
25.26%

3-Year Return

VICA
99.94%
S&P 500
22.00%

5-Year Return

VICA
99.94%
S&P 500
74.29%

Compare To: VICA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VICA

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    12.20k

  • Enterprise Value

    12.20k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.04

  • Enterprise Value/EBITDA

    -0.00

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -599.91%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    335.15k

  • Net Income Avi to Common (ttm)

    -5.78M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.26k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.05M

Company Insights: VICA

People Also Watch